Design Therapeutics (DSGN) Other Working Capital Changes (2020)

Design Therapeutics (DSGN) posted quarterly Other Working Capital Changes of $300000.0 for Q1 2020.

Design Therapeutics (DSGN) Other Working Capital Changes (2020) Analysis & Trends

Design Therapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at $391000.0 in Q2 2026.

Other Working Capital Changes for Q2 2026 came in at $391000.0, up 186.5% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.1 million (up 454.52% YoY), and the FY2025 annual result was $1.4 million, up 708.85% from the prior year.
Other Working Capital Changes held at $300000.0 in Q1 2020.
Over five years, Other Working Capital Changes peaked at $1.9 million in Q3 2022 and troughed at -$1.2 million in Q1 2023.
A 5-year average of $180388.9 and a median of $339000.0 in 2026 frame the typical range for Other Working Capital Changes.
The widest annual swing landed in 2022, when Other Working Capital Changes surged 508.15%; it then tumbled 274.73% in 2023.
A 5-year view of Other Working Capital Changes shows it stood at $471000.0 in 2022, then tumbled by 274.73% to -$823000.0 in 2023, then advanced by 26.49% to -$605000.0 in 2024, then jumped by 245.45% to $880000.0 in 2025, then tumbled by 55.57% to $391000.0 in 2026.
Per Business Quant data, the three most recent Other Working Capital Changes figures were $391000.0 in Q2 2026, $287000.0 in Q1 2026, and $880000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Design Therapeutics	928.06 Mn	720.67 Mn	-

Download Data